Cannabinoid co-administration may enable reduced opioid doses for analgesia. This
updated systematic review on the opioid-sparing effects of cannabinoids considered …

Neuropathic pain represents a broad category of pain syndromes that include a wide variety
of peripheral and central disorders. The overall prevalence of neuropathic pain in the …

Background The past two decades have seen an increase in cannabis use due to both
regulatory changes and an interest in potential therapeutic effects of the substance, yet …

Medical Cannabis and its major cannabinoids (−)-trans-Δ9-tetrahydrocannabinol (THC) and
cannabidiol (CBD) are gaining momentum for various medical purposes as their therapeutic …

Abstract Background and Objective This systematic review evaluated the effectiveness,
tolerability and safety of cannabis‐based medicines (CbMs) for chronic non‐cancer pain …

Neuropathic pain management should not be restricted to pharmacotherapy but now
encompasses multiple approaches including particularly neuromodulation techniques …

Aims Patients with chronic health conditions not responding to conventional treatment can
access medicinal cannabis (MC) prescriptions from clinicians in Australia. We aimed to …

The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there
is a lack of long-term trials to assess the benefits and safety of MC treatment in this …

The combination of the ongoing opioid crisis, inappropriateness of long-term use of NSAIDs,
limited efficacy and tolerability of existing analgesics and the fact that no new analgesics …

Studies have shown that women are more susceptible to adverse effects (AEs) from
conventional drugs. This study aimed to investigate the differences of medical cannabis …